Evidence map›Paper›PMID 32313035›Full record

ArticleScientific reports2020

Prion protein N1 cleavage peptides stimulate microglial interaction with surrounding cells.

J A Carroll, B R Groveman, K Williams, R Moore, B Race, C L Haigh

Abstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Prion Protein: The Molecule of Many Forms and Faces.International journal of molecular sciences · 2022
    Review
  5. Review
  6. What is the role of lipids in prion conversion and disease?Frontiers in molecular neuroscience · 2022
    Review
  7. Article
  8. Review
  9. A 3D cell culture approach for studying neuroinflammation.Journal of neuroscience methods · 2021
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

J A CarrollLaboratory of Persistent Viral Diseases, National Institute of Allergy and Infectious Diseases, Division of Intramural Research, Rocky Mountain Laboratories, National Institutes of Health, 903 South 4th Street, Hamilton, MT, 59840, USA.ORCID http://orcid.org/0000-0003-4329-1488
B R GrovemanLaboratory of Persistent Viral Diseases, National Institute of Allergy and Infectious Diseases, Division of Intramural Research, Rocky Mountain Laboratories, National Institutes of Health, 903 South 4th Street, Hamilton, MT, 59840, USA.ORCID http://orcid.org/0000-0002-5059-7672
K WilliamsLaboratory of Persistent Viral Diseases, National Institute of Allergy and Infectious Diseases, Division of Intramural Research, Rocky Mountain Laboratories, National Institutes of Health, 903 South 4th Street, Hamilton, MT, 59840, USA.ORCID http://orcid.org/0000-0002-7400-6056
R MooreLaboratory of Persistent Viral Diseases, National Institute of Allergy and Infectious Diseases, Division of Intramural Research, Rocky Mountain Laboratories, National Institutes of Health, 903 South 4th Street, Hamilton, MT, 59840, USA.
B RaceLaboratory of Persistent Viral Diseases, National Institute of Allergy and Infectious Diseases, Division of Intramural Research, Rocky Mountain Laboratories, National Institutes of Health, 903 South 4th Street, Hamilton, MT, 59840, USA.ORCID http://orcid.org/0000-0002-5334-1023
C L HaighLaboratory of Persistent Viral Diseases, National Institute of Allergy and Infectious Diseases, Division of Intramural Research, Rocky Mountain Laboratories, National Institutes of Health, 903 South 4th Street, Hamilton, MT, 59840, USA. cathryn.haigh@nih.gov.ORCID http://orcid.org/0000-0001-7591-1149

Funding

Prion protein function in redox homeostasis and associated failure in prion diseaseZIAAI001219 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI HAIGH, CATHRYN · 2017 to 2025
$10.0M
6 · The paper itself

Abstract

Microglia act as the protective immune cell of the brain. By surveying the tissue to identify and rectify problems, they function to maintain the health of brain cells. The prion protein N-terminal cleavage fragment, N1, has demonstrated neuroprotective activities in vitro and in vivo. This study aimed to elucidate whether N1 could modulate microglial function and, if so, determine the consequences for the surrounding tissue. Using a mixed neuronal lineage and microglia co-culture system, we showed that N1 stimulation changed overall morphology and metabolism, suggesting enhanced cellular viability. Furthermore, N1 induced an increase in Cxcl10 secretion in the co-cultures. Recombinant Cxcl10, administered exogenously, mediated the changes in the mixed neuronal lineage culture morphology and metabolism in the absence of microglia, but no effect of Cxcl10 was observed on microglia cultured on their own. Direct cell-to-cell contact was required for N1 to influence microglia in the co-cultures, and this was linked with restructuring of microglial membrane composition to include a higher GM1 content at interaction sites with surrounding cells. Our findings show that N1 can play a regulatory role in microglial function in the context of an inter-connected network of cells by changing both cellular interaction sites and cytokine secretion.

Indexed as

AnimalsBrainCell CommunicationCell DifferentiationChemokine CXCL10Coculture TechniquesGene ExpressionGenes, ReporterG(M1) GangliosideGreen Fluorescent ProteinsLuminescent ProteinsMiceMice, KnockoutMicrogliaNeural Stem CellsNeuronsChemokine CXCL10Cxcl10 protein, mouseCxcr3 protein, mouseG(M1) GangliosideGreen Fluorescent ProteinsLuminescent ProteinsNeuroprotective AgentsPeptide FragmentsPrion ProteinsPrionsReceptors, CXCR3Red Fluorescent Protein

Identifiers

PMID32313035
PMCPMC7171115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.